SEARCH

SEARCH BY CITATION

References

  • 1
    Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1989; 40: 243288.
  • 2
    Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 1993; 12: 151.
  • 3
    Gonzalez FJ. Human cytochromes P450: problems and prospects. Trends Pharmacol Sci 1992; 13: 346352.
  • 4
    Cholerton S, Daly AK, Idle JR. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol Sci 1992; 13: 434439.
  • 5
    Maurel P. The CYP3A family. In: LoannidesC, ed. Cytochromes P450: Metabolic and Toxicological Aspects. Boca Raton, FL: CRC Press, 1996: 241270.
  • 6
    Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindivid-ual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270: 414423.
  • 7
    Guengerich FP. Characterization of roles of human cytochrome P-450 enzymes in carcinogen metabolism. Asia Pacific J Pharmacol 1990; 5: 327345.
  • 8
    Pichard L, Fabre I, Fabre G, Domergue J, Saint Aubert B, Mourad G, Maurel P. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos 1990; 18: 595606.
  • 9
    Schuetz EG, Schuetz JD, Strom SC, Thompson MT, Fisher RA, Molowa DT, Li D, et al. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 1993; 18: 12541262.
  • 10
    Morel F, Beaune P, Ratanasavanh D, Flinois JP, Yang CS, Guengerich FP, Guillouzo A. Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur J Biochem 1990; 191: 437444.
  • 11
    Komori M, Nishio K, Ohi H, Kitada M, Kamataki T. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P450. J Biochem (Tokyo) 1989; 105: 161163.
  • 12
    Komori M, Nishio K, Kitada M, Shiramatsu K, Muroya K, Soma M, Naga-shima K, et al. Fetus-specific expression of a form of cytochrome P450 in human liver. Biochemistry 1990; 29: 44304433.
  • 13
    Schuetz JD, Beach DL, Guzelian PS. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacoge-netics 1994; 4: 1120.
  • 14
    Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, et al. Studies on the expression and metabolic capability of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 1990; 38: 207213.
  • 15
    Quattrochi LC, Tukey RH. The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction. J Biol Chem 1994; 269: 69496954.
  • 16
    Kawajiri K, Hayashi SI. The CYP1 family. In: IoannidesC, ed. Cytochromes P450: Metabolic and Toxicological Aspects. Boca Raton, FL: CRC Press, 1996: 7798.
  • 17
    Kimura S, Donovan JC, Nebert DW. Expression of the mouse Pl-450 gene during differentiation without foreign chemical stimulation. J Exp Pathol 1987; 3: 6174.
  • 18
    Jean Marie I, Dalet C, Blanchard JM, Astre C, Szawlowski A, Saint Aubert B, Joyeux H, et al. Inhibition of cytochrome P-450p (P450IIIA1) gene expression during liver regeneration from two-thirds hepatectomy in the rat. Biochem Pharmacol 1988; 37: 35153521.
  • 19
    Liddle C, Murray M, Farrell GC. Effect of liver regeneration on hepatic cytochrome P450 isozymes and serum sex steroids in the male rat. Gastro-enterology 1989; 96: 864872.
  • 20
    Tsuboushi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by enzyme-linked im-munosorbent assay. Hepatology 1991; 13: 15.
  • 21
    Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Jujiwara F. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology 1992; 103: 16211624.
  • 22
    Shiota G, Okano JI, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995; 21: 106112.
  • 23
    Michalopoulos G, Jirtle RL, Kligerman AD, Cianciulli D, Novotny A. Liver regeneration studies in primary cultures of hepatocytes. Cancer Res 1982; 42: 46734682.
  • 24
    Tomomura A, Sawada N, Sattler GL, Kleinman HK, Pitot HC. The control of DNA synthesis in primary cultures of hepatocytes from adult and young rats: interactions of extracellular matrix components, epidermal growth factor, and cell cycle. J Cell Physiol 1987; 130: 221227.
  • 25
    Blanc P, Etienne H, Daujat M, Fabre I, Zindy F, Domergue J, Astre C, et al. Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor α, and human serum. Gastroenterology 1992; 102: 13401350.
  • 26
    Diaz D, Fabre I, Daujat M, Saint Aubert B, Bories P, Michel H, Maurel P. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 1990; 99: 737747.
  • 27
    Daujat M, Pichard L, Pineau T, Fabre G, Bonfils C, Maurel P. Induction protocols for cytochromes P450IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods Enzymol 1991; 206: 345353.
  • 28
    Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, Maurel P. Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J 1992; 6: 752758.
  • 29
    Pichard L, Fabre I, Daujat M, Domergue J, Joyeux H, Maurel P. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. Mol Pharmacol 1992; 41: 10471055
  • 30
    Curi-Pedrosa R, Daujat M, Pichard L, Ourlin JC, Clair P, Gervot L, Lesca P, et al. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. J Pharmacol Exp Ther 1994; 269: 384392.
  • 31
    Muntane-Relat J, Ourlin JC, Domergue J, Maurel P. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 1995; 22: 11431153.
  • 32
    Isom HC, Georgoff I. Quantitative assay for albumine-producing liver cells after simian virus 40 transformation of rat hepatocytes maintained in chemically denned medium. Proc Natl Acad Sci U S A 1984; 81: 63786382.
  • 33
    Bonfils C, Daujat M, Chevron MP, Dalet-Beluche I. Electrotransfer of microsomal cytochrome P450 after isoelectric focusing (IEF blot): resolution of human 2A and 3A isozymes. Anal Biochem 1994; 218: 8086.
  • 34
    French JS, Coon MJ. Properties of NADPH-cytochrome P-450 reductase purified from rabbit liver microsomes. Arch Biochem Biophys 1979; 195: 565577.
  • 35
    Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 52945299.
  • 36
    Melton DA, Krieg PA, Rabagliati MR, Maniatis T, Zinn K, Green MR. Efficientin vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 1984; 12: 70357056.
  • 37
    Michalopoulos GK Liver regeneration: molecular mechanisms of growth control. FASEB J 1990; 4: 176187.
  • 38
    Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure and implications for a centrol role in liver regeneration. J Gastroen-terol Hepatol 1991; 6: 509519.
  • 39
    Blanc P, Liautard J, Greuet J, Daures JP, Fabre JM, Larrey D, Michel H, Maurel P. Effect of anti-ulcer drugs on DNA synthesis in adult normal human hepatocytes in culture. Hepatology 1995; 22: 814819.
  • 40
    Greuet J, Pichard L, Bonfils C, Domergue J, Maurel P. The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture. Biochem Biophys Res Commun 1996; 225: 689694.
  • 41
    Donohue TM, Tuma DJ, Sorrell MF. Plasma protein metabolism. In: ZakimD, BoyerT, eds. Hepatology. A Text Book of Liver Disease. Ed. 3 Philadelphia: Saunders, 1996: 130148.
  • 42
    Loyer P, Cariou S, Glaise D, Bilodeau M, Baffet G, Guguen-Guillouzo C. Growth factor dependence of progression through Gl and S phase of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late Gl. J Biol Chem 1996; 271: 1148411492.
  • 43
    Fausto N, Laird AD, Webber EM. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995; 9: 15271536.
  • 44
    Gomez-Lechon MJ, Castell J, Guillen I, O'Connor E, Nakamura T, Fabra R, Trullenque R. Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture. Hepatology 1995; 21: 12481254.
  • 45
    Ismail T, Howl J, Wheatley M, McMaster P, Neuberger JM, Strain AJ. Growth of normal human hepatocytes in primary cultures. Effect of hormones and growth factors on DNA synthesis. Hepatology 1992; 14: 10761082.
  • 46
    Kitada M, Tsukidate K, Takeushi J, Taneda M, Komori M, Ohi H, Itahashi K, et al. Immunochemical studies for the presence of P-450 HFLa, a form of cytochrome P-450 in human fetal livers, in human hepatocellular carcinoma cells. Pharmacobio-Dyn 1989; 12: 341344.
  • 47
    Lai E, Darnell JE. Transcription control in hepatocytes: a window on development. Trends Biochem Sci 1991; 16: 427430.
  • 48
    Rana B, Mischoulson D, Xie Y, Bucher NLR, Farmer SR. Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBPα and immediate-early growth response transcription factors. Mol Cell Biol 1994; 14: 58585869.
  • 49
    Taub R. Transcriptional control of liver regeneration. FASEB J 1996; 10: 413427.
  • 50
    McKnight SL, Lane MD, Gluecksohn-Waelsch S. Is CCAAT/enhancer-binding protein a central regulator of energy metabolism? Genes Dev 1989; 3: 20212024.
  • 51
    Andersson GM, Shaw AR, Shafer JA. Functional characterization of promoter elements involved in regulation of human Bβ-fibrinogen expression. Evidence for binding of novel activator and represser proteins. J Biol Chem 1993; 268: 2265022655.
  • 52
    Paulweber B, Levy-Wilson B. The mechanism by which a human apolipo-protein B gene enhancer and reducer interact with the promoter are different in cultured cells of hepatic and intestinal origin. J Biol Chem 1991; 266: 2416124168.
  • 53
    Ourlin JC, Jounaidi Y, Maurel P, Vilarem MJ. Role of the liver-enriched transcription factors C/EBPα and DBF in the expression of human CYP3A4 and CYP3A7. J Hepatol 1997; in press.
  • 54
    Corlu A, Kneip B, Lhadi C, Leray G, Glaise D, Baffet G, Bourel D, et al. A plasma membrane protein is involved in cell contact-mediated regulation of tissue-specific genes in adult hepatocytes. J Cell Biol 1991; 115: 505515.
  • 55
    Traub O, Drüge PM, Willecke K Degradation and resynthesis of gap junction protein in plasma membranes of regenerating liver after partial hepa-tectomy or cholestasis. Proc Natl Acad Sci U S A 1983; 80: 755759.